MyFinsight
Home
Blog
About
Contact
Download
Download image
Marketable investment
securities
$9,724,545
Cash and cash
equivalents
$5,205,842
License fee and
royalties receivable
$1,145,390
Prepaid and other
current assets
$787,600
Accrued interest income
$14,189
Property and equipment,
gross
$1,388,372
Total current assets
$16,877,566
Property and equipment,
net of accumulated...
$104,293
Other assets
$23,753
Less accumulated
depreciation
$1,284,079
Total assets
$17,005,612
Total liabilities and
stockholders equity
$17,005,612
Total stockholders
equity
$14,477,416
Total liabilities
$2,528,196
Accumulated deficit
-$209,396,367
Treasury stock at cost,
336 shares
$40,712
Additional paid-in capital
$223,901,106
Total current
liabilities
$2,528,196
Common stock, par value
0.0001 per share,...
$8,944
Accumulated other
comprehensive gain
$4,445
Accrued expenses
$1,236,374
Accounts payable
$971,822
Deferred revenue
$320,000
Back
Back
Balance Sheet
source: myfinsight.com
Lipocine Inc. (LPCN)
Lipocine Inc. (LPCN)